Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome

Published:2008-12-01 Issue:9 Volume:43 Page:739-740
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ohwada C,Nakaseko C,Sakai S,Takeda Y,Abe D,Takeuchi M,Sakaida E,Masuda S,Shimizu N,Cho R,Nishimura M,Kanai K,Misawa S,Kuwabara S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2008381.pdf

Reference10 articles.

1. Dispenzieri A . POEMS syndrome. Blood Rev 2007; 21: 285–299.

2. Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008; 80: 397–406.

3. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104: 3400–3407.

4. Badros A, Porter N, Zimrin A . Bevacizumab therapy for POEMS syndrome. Blood 2005; 106: 1135.

5. Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007; 92: 1438–1439.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. POEMS syndrome in the 21st century: A bibliometric analysis;Heliyon;2023-10

2. POEMS syndrome: Update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-09-21

3. Recent Advances in the Treatment and Supportive Care of POEMS Syndrome;Journal of Clinical Medicine;2022-11-27

4. Monoclonal Gammopathies with Miscellaneous Associations;Paraproteinemia and Related Disorders;2022

5. POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2021-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3